✦ LIBER ✦

P215B Evaluation of the cost-effectiveness of Oncotype-DX® multigene assay in Hungary

✍ Scribed by B. Madaras; P. Rózsa; Z. Gerencsér; T. Radovics; I. Láng; Z. Nagy; Z. Horváth

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN12 COST-EFFECTIVENESS OF THE ONCOTYPE

✍ O'Leary, B; Foteff, C; Byron, K; Chang, C; Chao, C; Ng, C; Skrzypczak, S 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Oncotype DX assay cost effective in earl

✍ Laschober, Tanja C.; Tormes Eby, Lillian Turner 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl ⚖ 111 KB

347 The Impact of Chemotherapeutic Regim

✍ B. Madaras; P. Rózsa; Z. Gerencsér; T. Radovics; I. Lang; Z. Nagy; Z. Horváth 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Cost-Effectiveness Analysis Of The Use O

✍ Plun-Favreau, J.; Suarez, S.; Chivardy, H.; Pozo, L. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Evaluating a Role for Oncotype Dx Breast

✍ Chadha, M.; Fox, J.; Boolbol, S.K.; Kabarrati, R.; Patricia Cate, S.; Radzio, A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 44 KB

The impact of the Oncotype Dx breast can

✍ Carlson, Josh J.; Roth, Joshua A. 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 351 KB